MedPath

Effects of multi-strain probiotic and prebiotic supplementation on body composition, biochemical blood profiles, and gut microbiomes in overweight and obese subjects

Phase 3
Completed
Conditions
Obesity, overweight
Registration Number
TCTR20220828002
Lead Sponsor
ATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
63
Inclusion Criteria

Overweight and obesity (BMI of 23-30 kg/m2)

Exclusion Criteria

Subjects with hypertension, type 2 diabetes, used medicine of previous or current treatment for gastrointestinal diseases, chronic diseases, thyroid abnormality or immune-compromising disease, hepatitis, cancer, transplant patient, used probiotic supplement 2 weeks before screening, used antibiotic medicine before 4 weeks, used medicine affecting bodyweight, energy expenditure, or glucose for last 3 months, used vitamin and mineral supplement within 6 months before screening, current smoker, alcohol drinking, pregnant or lactation were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
body composition 0, 6 wk, 12 wk BMI, Weight, Waist circumference, %fat
Secondary Outcome Measures
NameTimeMethod
gut microbiomes 0, 12 wk Sequencing bacteria analysis,Biochemical assessment 0,6,12 wk Plasma glucose, cholesterol, triglyceride, HDL, LDL, ALT, AST, B
© Copyright 2025. All Rights Reserved by MedPath